BDRX
Price
$0.85
Change
+$0.01 (+1.19%)
Updated
Jul 17 closing price
Capitalization
4.3M
PHGE
Price
$0.40
Change
+$0.02 (+5.26%)
Updated
Jul 17 closing price
Capitalization
10.42M
Interact to see
Advertisement

BDRX vs PHGE

Header iconBDRX vs PHGE Comparison
Open Charts BDRX vs PHGEBanner chart's image
Biodexa Pharmaceuticals
Price$0.85
Change+$0.01 (+1.19%)
Volume$321.2K
Capitalization4.3M
BiomX
Price$0.40
Change+$0.02 (+5.26%)
Volume$672.07K
Capitalization10.42M
BDRX vs PHGE Comparison Chart in %
Loading...
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDRX vs. PHGE commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDRX is a Hold and PHGE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (BDRX: $0.85 vs. PHGE: $0.40)
Brand notoriety: BDRX and PHGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDRX: 11% vs. PHGE: 44%
Market capitalization -- BDRX: $4.3M vs. PHGE: $10.42M
BDRX [@Biotechnology] is valued at $4.3M. PHGE’s [@Biotechnology] market capitalization is $10.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDRX’s FA Score shows that 1 FA rating(s) are green whilePHGE’s FA Score has 1 green FA rating(s).

  • BDRX’s FA Score: 1 green, 4 red.
  • PHGE’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDRX and PHGE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDRX’s TA Score shows that 5 TA indicator(s) are bullish while PHGE’s TA Score has 4 bullish TA indicator(s).

  • BDRX’s TA Score: 5 bullish, 3 bearish.
  • PHGE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BDRX is a better buy in the short-term than PHGE.

Price Growth

BDRX (@Biotechnology) experienced а -4.22% price change this week, while PHGE (@Biotechnology) price change was -2.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.06%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +40.41%.

Reported Earning Dates

BDRX is expected to report earnings on Apr 11, 2025.

PHGE is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHGE($10.4M) has a higher market cap than BDRX($4.3M). PHGE YTD gains are higher at: -45.487 vs. BDRX (-78.963).
BDRXPHGEBDRX / PHGE
Capitalization4.3M10.4M41%
EBITDAN/A-6.21M-
Gain YTD-78.963-45.487174%
P/E RatioN/A0.02-
RevenueN/A0-
Total CashN/A20.1M-
Total DebtN/A9.29M-
FUNDAMENTALS RATINGS
BDRX vs PHGE: Fundamental Ratings
BDRX
PHGE
OUTLOOK RATING
1..100
3333
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9693
P/E GROWTH RATING
1..100
9583
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDRX's Valuation (20) in the Biotechnology industry is in the same range as PHGE (28) in the null industry. This means that BDRX’s stock grew similarly to PHGE’s over the last 12 months.

BDRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PHGE (100) in the null industry. This means that BDRX’s stock grew similarly to PHGE’s over the last 12 months.

PHGE's SMR Rating (98) in the null industry is in the same range as BDRX (99) in the Biotechnology industry. This means that PHGE’s stock grew similarly to BDRX’s over the last 12 months.

PHGE's Price Growth Rating (93) in the null industry is in the same range as BDRX (96) in the Biotechnology industry. This means that PHGE’s stock grew similarly to BDRX’s over the last 12 months.

PHGE's P/E Growth Rating (83) in the null industry is in the same range as BDRX (95) in the Biotechnology industry. This means that PHGE’s stock grew similarly to BDRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDRXPHGE
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
75%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RRX152.326.37
+4.36%
Regal Rexnord Corp
RWAY11.310.21
+1.89%
Runway Growth Finance Corp
CCRD28.570.36
+1.28%
CoreCard Corp
BKYI0.830.01
+1.09%
BIO-key International
SNEX91.850.25
+0.27%
StoneX Group Inc

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with LVTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
+1.67%
LVTX - BDRX
41%
Loosely correlated
-0.71%
ATNF - BDRX
40%
Loosely correlated
+107.88%
FHTX - BDRX
34%
Loosely correlated
+3.74%
KRRO - BDRX
33%
Loosely correlated
+5.09%
SCNI - BDRX
32%
Poorly correlated
-0.77%
More

PHGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHGE has been loosely correlated with APM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PHGE jumps, then APM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHGE
1D Price
Change %
PHGE100%
+3.92%
APM - PHGE
60%
Loosely correlated
+1.55%
HOFBF - PHGE
35%
Loosely correlated
N/A
BDRX - PHGE
26%
Poorly correlated
+1.67%
AVTX - PHGE
26%
Poorly correlated
+16.70%
KYMR - PHGE
25%
Poorly correlated
+1.85%
More